S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
How does the Consumer Price Index affect the stock market?
A 'soft landing' or a recession? How each one might affect America's households and businesses
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Carrier Global, Marathon Oil rise; RH, Newmont fall, Friday, 12/8/2023
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
How major US stock indexes fared Friday, 12/8/2023
FTC opens inquiry of Chevron-Hess merger, marking second review this week of major oil industry deal

CRISPR Therapeutics (CRSP) Institutional Ownership

$64.54
-5.67 (-8.08%)
(As of 12/8/2023 ET)
Compare
Today's Range
$61.55
$76.97
50-Day Range
$38.62
$72.18
52-Week Range
$37.55
$76.97
Volume
17.23 million shs
Average Volume
2.85 million shs
Market Capitalization
$5.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$69.88

Institutional Ownership Changes (13F Filings) for CRISPR Therapeutics (NASDAQ:CRSP)

Current
Institutional Ownership
Percentage
68.20%
Number of
Institutional Buyers
(last 12 months)
226
Total
Institutional Inflows
(last 12 months)
$352.90 M
Number of
Institutional Sellers
(last 12 months)
135
Total
Institutional Outflows
(last 12 months)
$321.32 M
Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CRSP Institutional Buying and Selling by Quarter


CRISPR Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/7/2023Hudson Bay Capital Management LP10,000$0.45M0.0%-66.7%0.013%
12/6/2023Citigroup Inc.112,111$5.09M0.0%+3.3%0.141%
12/1/2023B. Riley Wealth Advisors Inc.16,810$0.76M0.0%+104.7%0.021%
11/30/2023American Century Companies Inc.13,732$0.62M0.0%+9.8%0.017%
11/28/2023IMA Wealth Inc.25,517$1.16M0.3%-1.0%0.032%
11/16/2023Integrated Advisors Network LLC7,203$0.33M0.0%N/A0.009%
11/16/2023Creative Planning14,950$0.68M0.0%+61.7%0.019%
11/16/2023Spouting Rock Asset Management LLC10,008$0.45M0.1%-30.0%0.013%
11/16/2023Front Row Advisors LLC836$38K0.0%-95.0%0.001%
11/16/2023Penserra Capital Management LLC4,884$0.22M0.0%+26.5%0.006%
11/15/2023WealthPlan Investment Management LLC9,375$0.43M0.1%+16,063.8%0.012%
11/15/2023Mercer Global Advisors Inc. ADV10,985$0.50M0.0%+3.7%0.014%
11/15/2023The Manufacturers Life Insurance Company 29,393$1.33M0.0%+31.2%0.037%
11/15/2023Royal Bank of Canada96,935$4.40M0.0%-2.1%0.122%
11/15/2023Schroder Investment Management Group125,013$5.67M0.0%-1.4%0.157%
11/15/2023Scotia Capital Inc.9,216$0.42M0.0%-4.3%0.012%
11/15/2023Sei Investments Co.55,455$2.52M0.0%-4.2%0.070%
11/15/2023Seven Eight Capital LP16,179$0.73M0.1%N/A0.020%
11/15/2023JPMorgan Chase & Co.520,429$23.62M0.0%-5.6%0.655%
11/15/2023Legal & General Group Plc67,150$3.05M0.0%+4.2%0.085%
11/15/2023Ameriprise Financial Inc.115,374$5.23M0.0%-10.8%0.145%
11/15/2023Armistice Capital LLC600,012$27.24M0.4%+20.0%0.755%
11/15/2023Axxcess Wealth Management LLC7,781$0.35M0.0%-12.6%0.010%
11/15/2023Advisors Asset Management Inc.7,218$0.33M0.0%+26.4%0.009%
11/14/2023Lazard Asset Management LLC115,514$5.24M0.0%-2.8%0.145%
11/14/2023Corton Capital Inc.5,409$0.25M0.1%+6.1%0.007%
11/14/2023Ancora Advisors LLC1,330$60K0.0%+111.1%0.002%
11/14/2023Itau Unibanco Holding S.A.2,521$0.11M0.0%+10.8%0.003%
11/14/2023California State Teachers Retirement System66,308$3.01M0.0%+0.9%0.083%
11/14/2023Tower Research Capital LLC TRC 4,271$0.19M0.0%-68.8%0.005%
11/14/2023Qube Research & Technologies Ltd3,698$0.17M0.0%-17.9%0.005%
11/14/2023Westfield Capital Management Co. LP297,550$13.51M0.1%N/A0.375%
11/14/2023Merlin Capital Inc9,092$0.41M1.5%+3.3%0.011%
11/14/2023Profund Advisors LLC29,268$1.33M0.1%+21.5%0.037%
11/13/2023C M Bidwell & Associates Ltd.3,119$0.14M0.1%+28.7%0.004%
11/13/2023Natixis Advisors L.P.11,707$0.53M0.0%-2.6%0.015%
11/13/2023Jaffetilchin Investment Partners LLC4,949$0.23M0.0%+19.6%0.006%
11/13/2023Northern Trust Corp244,248$11.09M0.0%+2.1%0.308%
11/13/2023Federated Hermes Inc.508,100$23.06M0.1%-0.1%0.640%
11/13/2023Stifel Financial Corp26,879$1.22M0.0%-6.9%0.034%
11/13/2023Mariner LLC7,490$0.34M0.0%+14.3%0.009%
11/13/2023Interchange Capital Partners LLC5,765$0.26M0.2%+6.1%0.007%
11/13/2023Invesco Ltd.136,123$6.18M0.0%+1.5%0.171%
11/13/2023FMR LLC2,057,414$93.39M0.0%-1.6%2.590%
11/13/2023Envestnet Asset Management Inc.28,620$1.30M0.0%+58.9%0.036%
11/13/2023Nordea Investment Management AB108,100$5.04M0.0%+13.4%0.136%
11/13/2023Envestnet Portfolio Solutions Inc.4,427$0.20M0.0%N/A0.006%
11/13/2023Rafferty Asset Management LLC189,387$8.60M0.1%+28.9%0.238%
11/13/2023Baillie Gifford & Co.441,063$20.02M0.0%+81.1%0.555%
11/13/2023Kestra Advisory Services LLC5,628$0.26M0.0%-7.7%0.007%
11/13/2023Bank Julius Baer & Co. Ltd Zurich19,856$0.90M0.0%+208.4%0.025%
11/13/2023PNC Financial Services Group Inc.6,808$0.31M0.0%+159.4%0.009%
11/13/2023E Fund Management Co. Ltd.9,157$0.42M0.0%+25.5%0.012%
11/9/2023Loomis Sayles & Co. L P1,096,354$49.76M0.1%-4.5%1.381%
11/9/2023Oliver Lagore Vanvalin Investment Group612$28K0.0%-24.9%0.001%
11/9/2023Citigroup Inc.112,111$5.09M0.0%+3.3%0.141%
11/9/2023Headlands Technologies LLC754$34K0.0%N/A0.001%
11/9/2023Mitsubishi UFJ Trust & Banking Corp48,520$2.20M0.0%+65.7%0.061%
11/8/2023Van ECK Associates Corp72,830$3.31M0.0%-5.1%0.092%
11/8/2023Charles Schwab Investment Management Inc.637,938$28.96M0.0%-1.4%0.803%
11/8/2023Janney Montgomery Scott LLC13,087$0.59M0.0%+83.7%0.016%
11/8/2023Spire Wealth Management1,052$48K0.0%+32.7%0.001%
11/8/2023Swiss National Bank164,800$7.48M0.0%+1.3%0.208%
11/8/2023Value Star Asset Management Hong Kong Ltd17,650$0.80M0.3%N/A0.022%
11/8/2023Oppenheimer & Co. Inc.21,998$1M0.0%+15.6%0.028%
11/7/2023Cutler Group LLC CA2,000$90K0.0%-30.1%0.003%
11/7/2023Barclays PLC510,832$23.19M0.0%+36.9%0.643%
11/7/2023Fox Run Management L.L.C.4,511$0.21M0.1%-34.0%0.006%
11/7/2023Jump Financial LLC33,307$1.51M0.1%+194.7%0.042%
11/7/2023Arizona State Retirement System21,351$0.97M0.0%+1.7%0.027%
11/6/2023Privium Fund Management B.V.7,200$0.33M0.1%+20.0%0.009%
11/4/2023Signaturefd LLC2,124$96K0.0%+12.5%0.003%
11/3/2023Liberty One Investment Management LLC3,376$0.15M0.0%-7.5%0.004%
11/3/2023Loring Wolcott & Coolidge Fiduciary Advisors LLP MA1,035$48K0.0%+137.9%0.001%
11/3/2023SteelPeak Wealth LLC5,780$0.26M0.0%+14.6%0.007%
11/3/2023Private Advisor Group LLC5,654$0.25M0.0%+12.3%0.007%
11/3/2023Lincoln Capital Corp4,500$0.20M0.1%N/A0.006%
11/2/2023EFG Asset Management North America Corp.82,672$3.75M0.9%+10.3%0.104%
11/2/2023California Public Employees Retirement System112,169$5.09M0.0%+5.9%0.141%
11/2/2023Capital Investment Advisory Services LLC30,781$1.40M0.1%+3.1%0.039%
11/2/2023FDx Advisors Inc.6,328$0.29M0.0%-21.7%0.008%
11/1/2023Congress Asset Management Co. MA40,260$1.83M0.0%N/A0.051%
11/1/2023Jacob Asset Management of New York LLC4,003$0.18M0.3%+10.8%0.005%
10/31/2023Teacher Retirement System of Texas21,284$0.97M0.0%+5.0%0.027%
10/31/2023Hedges Asset Management LLC22,525$1.02M0.9%+18.9%0.028%
10/31/2023China Universal Asset Management Co. Ltd.2,041$93K0.0%+97.4%0.003%
10/30/2023Tradewinds Capital Management LLC710$32K0.0%+545.5%0.001%
10/30/2023Del Sette Capital Management LLC33,977$1.54M1.5%+0.9%0.043%
10/30/2023Arete Wealth Advisors LLC11,601$0.53M0.1%+8.1%0.015%
10/30/2023Perigon Wealth Management LLC14,309$0.65M0.0%+25.7%0.018%
10/30/2023Sumitomo Mitsui Trust Holdings Inc.3,465,470$157.30M0.1%-1.9%4.364%
10/27/2023Hennion & Walsh Asset Management Inc.15,315$0.70M0.0%+89.5%0.019%
10/27/2023Allspring Global Investments Holdings LLC287,394$13.05M0.0%-12.0%0.362%
10/27/2023First Horizon Advisors Inc.1,555$71K0.0%-25.8%0.002%
10/27/2023TD Asset Management Inc240,462$10.92M0.0%+12.9%0.303%
10/26/2023Mirae Asset Global Investments Co. Ltd.184,854$8.39M0.0%+10.3%0.233%
10/25/2023BluePath Capital Management LLC825$37K0.0%N/A0.001%
10/25/2023Zurcher Kantonalbank Zurich Cantonalbank 18,527$0.84M0.0%+11.3%0.023%
10/25/2023Intellectus Partners LLC8,556$0.39M0.1%+8.2%0.011%
10/24/2023Bank of New York Mellon Corp105,415$4.79M0.0%-2.5%0.133%
(Data available from 1/1/2016 forward)













CRSP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRSP shares?

During the previous two years, 412 institutional investors and hedge funds held shares of CRISPR Therapeutics. The most heavily invested institutionals were Capital International Investors ($340.75M), ARK Investment Management LLC ($325.13M), Nikko Asset Management Americas Inc. ($178.75M), Sumitomo Mitsui Trust Holdings Inc. ($157.30M), BlackRock Inc. ($152.62M), T. Rowe Price Investment Management Inc. ($121.69M), and Vanguard Group Inc. ($93.80M).Learn more on CRSP's institutional investors.

What percentage of CRISPR Therapeutics stock is owned by institutional investors?

68.20% of CRISPR Therapeutics stock is owned by institutional investors. Learn more on CRSP's institutional investor holdings.

Which institutional investors have been buying CRISPR Therapeutics stock?

Of the 368 institutional investors that purchased CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sumitomo Mitsui Trust Holdings Inc. ($4.62M), Price T Rowe Associates Inc. MD ($1.85M), BlackRock Inc. ($1.37M), State Street Corp ($1.36M), Nikko Asset Management Americas Inc. ($1.33M), Vanguard Group Inc. ($0.99M), and Macquarie Group Ltd. ($0.92M).

How much institutional buying is happening at CRISPR Therapeutics?

Institutional investors have bought a total of 29,292,785 shares in the last 24 months. This purchase volume represents approximately $1.77B in transactions.

Which CRISPR Therapeutics major shareholders have been selling company stock?

Of the 218 institutional investors that sold CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Price T Rowe Associates Inc. MD ($1.91M), ARK Investment Management LLC ($1.24M), Sumitomo Mitsui Trust Holdings Inc. ($1.15M), Macquarie Group Ltd. ($0.88M), Renaissance Technologies LLC ($0.63M), Capital International Investors ($0.59M), and State Street Corp ($0.45M).

How much institutional selling is happening at CRISPR Therapeutics?

Institutional investors have sold a total of 13,028,838 shares in the last 24 months. This volume of shares sold represents approximately $728.86M in transactions.


This page (NASDAQ:CRSP) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -